Diabetes & CV Disease
Sort by:
Practical Ways to Achieve Targets in Diabetes Care
Adjunctive Therapies in Type 1 Diabetes: Anything Useful Besides Insulin
FEATURING
John Buse
- 977 views
- July 31, 2023
- 9
University of Texas Southwestern Medical Center
Weight Wellness for the PCP: The Next Generation of Anti-Obesity Medications
FEATURING
Jaime Almandoz
- 2,300 views
- April 2, 2024
- 9
Primary Care Education Consortium
Cardiovascular and Kidney Outcomes With Glucose-Lowering Agents
FEATURING
James Gavin Iii
- 990 views
- November 21, 2023
- 8
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Approaches to Treating Diabetes that Reduce CV Events: How Effective Are DPP-4 Inhibitors, GLP1-Receptor Agonists and SGLT-2 Inhibitors in Reducing MACE and Preventing HF Events?
FEATURING
Jia Shen
- 343 views
- February 5, 2021
- 4
Heart in Diabetes (HiD)
Hypertension Awakenings: Finally Something New to Talk About
FEATURING
Raymond R. Townsend
- 1,249 views
- October 7, 2024
- 10
Omnipod®
Initiating Your Patients on the Omnipod 5® Automated Insulin Delivery System
- 162 views
- July 21, 2023
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Obesity, Diabetes and Cancer Risk
FEATURING
Derek LeRoith
- 2,241 views
- June 16, 2017
- 8
KDIGO
Cardiovascular Benefits Associated with Current Pharmacotherapies in Patients with CKD and Diabetes
FEATURING
Erin Michos
- 345 views
- January 24, 2022
- 4
Primary Care Education Consortium
Treatment Approaches for Obesity: Pharmacologic
FEATURING
Robert Kushner
- 1,976 views
- February 27, 2024
- 10
Penn Medicine Heart and Vascular Center
Diabetes Monitoring: What Do I Do With All of This Data and What Are the Goals?
FEATURING
Mark Schutta
- 346 views
- November 21, 2023
- 4
Practical Ways to Achieve Targets in Diabetes Care
CGMs and AID Systems: Q&A/ Panel Discussion
- 164 views
- July 26, 2023
- 2
Virtual EP Connect
GLP Agonists & Cardiovascular Health: SELECT and ONWARDS
FEATURING
Vivek Reddy,
Francis Marchlinski,
Robert Kushner,
Bradley Knight,
Andrea Russo,
Gianluca Iacobellis
- 454 views
- June 27, 2024
- 4
ACC 2024 Insights
ACC 2024 Insights: Use of Guidelines in Treatment of Chronic Coronary Disease in Older Adults
FEATURING
John Mulrow
- 1,045 views
- April 16, 2024
- 9
Keck School of Medicine of USC
What's New in the Medical Management of Diabetes? A 2024 Guidelines Update
FEATURING
Alyssa Lampe Dominguez
- 1,381 views
- October 21, 2024
- 10
Cleveland Clinic Endocrinology & Metabolism Institute
The Challenge of Hypertriglyceridemia
FEATURING
Michelle Lundholm
- 1,794 views
- January 27, 2022
- 10
Cedars Sinai
SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial
FEATURING
Sanjay Kaul,
Milton Packer
- 1,787 views
- February 7, 2022
- 9
ASPC 2019 Congress on CVD Prevention
Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients With Diabetes
FEATURING
Robert Chilton
- 1,411 views
- August 9, 2019
- 10
ACC 2022 Conference Coverage
ACC 2022: SGLT2i in Heart Failure - HFrEF, HFpEF, Class Effect?
FEATURING
Stephen Greene
- 1,454 views
- April 12, 2022
- 10
Scripps Health
Diabetes and Mental Health: Diabetes, Depression, and Eating Disorders
FEATURING
Nusha Nouhi
- 258 views
- December 8, 2023
- 3
KDIGO
ISN-KDIGO Webinar Series on Complement in GN: Complement in DKD
FEATURING
Sydney Tang
- 167 views
- September 28, 2022
- 2
ESC 2023 Insights
ESC 2023 Insights: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
FEATURING
Nikolaus Marx
- 1,104 views
- September 20, 2023
- 9
Heart, Diabetes and Kidney: Make the Link
Highlights From the ADA 2022 Scientific Sessions
FEATURING
Pam Taub
- 727 views
- June 28, 2022
- 7